台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    78.9
  • 漲跌
    ▼0.6
  • 漲幅
    -0.75%
  • 成交量
    435
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
中裕 (4147)籌碼相關-群益金鼎-大安 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-大安 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/2400.007579.1579.60-751,879-3.99%
2025/04/1700.00580.5079.40-52,001-0.25%
2025/04/1600.001479.2278.90-142,135-0.66%
2025/04/1500.00178.0077.80-12,347-0.04%
2025/04/1400.001077.6877.20-102,375-0.42%
2025/04/103373.4000.0073.40332,3721.39%
2025/04/0900.009566.8266.80-952,377-4.00%
2025/04/0800.0011071.4571.30-1102,331-4.72% 大賣/鉅額交易
2025/04/0700.00579.2079.20-52,292-0.22%
2025/03/31289.7000.0088.0022,2770.09%
2025/03/26298.101599.2098.10-132,230-0.58%
2025/03/25298.60599.3298.60-32,210-0.14%
2025/03/241499.001099.2599.0042,1920.18%
2025/03/21796.7700.0096.4072,1490.33%
2025/03/2000.001094.9095.80-102,123-0.47%
2025/03/191093.1000.0092.80102,0980.48%
2025/03/181091.9100.0091.90102,0850.48%
2025/03/131097.501093.8091.6002,0990.00%
2025/03/0500.00097.9098.6001,9240.00%
2025/03/0400.001092.4495.50-101,904-0.53%
2025/02/271096.201596.5395.50-51,878-0.27%
2025/02/2600.0010100.7598.00-101,886-0.53%
2025/02/2540100.2540101.3199.3001,8560.00%
2025/02/2440100.0035101.5099.3051,7960.28%
2025/02/2175100.3480104.1998.90-51,727-0.29%
2025/02/2000.00198.9099.70-11,553-0.07%
2025/02/18594.0000.0094.0051,4910.34%
2025/02/17107103.9938105.1497.10691,4404.79% 大買/
2025/02/142399.30099.5398.90231,2261.87%
2025/02/1200.00093.3093.0001,1520.00%
2025/02/112091.8700.0091.70201,1401.75%
2025/02/071090.10088.6090.10101,1250.89%
2025/02/06084.20086.5087.8001,1150.00%
2025/02/05084.0000.0084.3001,1080.00%
2025/02/043284.0900.0083.30321,1142.87%
2025/01/14089.1000.0087.3001,1470.00%
2025/01/1300.00092.8089.9001,1320.00%
2025/01/10088.00090.3090.5001,0640.00%
2025/01/093094.63093.9587.50301,0142.95%
2025/01/0850100.000.1101.0097.2049.98725.73%
2025/01/0700.00089.9092.7006490.00%
2025/01/0600.00090.8089.8006110.00%
2024/12/0900.00088.6790.1006000.00%
2024/12/065189.46189.1887.60505738.72%
2024/12/03985.9000.0084.3095291.70%
2024/12/024185.4500.0084.20415247.81%
2024/11/2500.00084.7085.0005430.00%
2024/11/06081.2000.0080.8005280.00%
2024/10/3000.001083.2581.40-10601-1.66%
2024/10/2900.001080.1080.90-10588-1.70%
2024/10/28481.00484.2081.0005840.00%
2024/10/242081.9000.0080.80205723.49%
2024/10/2300.00081.5581.800570-0.01%
2024/10/221078.101079.6080.6005620.00%
2024/10/1400.00077.7074.0006140.00%
2024/10/08077.8200.0076.3006180.01%
2024/10/0700.00079.4077.800629-0.01%
2024/09/26080.4000.0080.2006500.01%
2024/09/2500.001082.2182.20-10651-1.53%
2024/09/241081.5000.0081.10106401.56%
2024/08/3000.00087.2086.4007500.00%
2024/06/19090.2000.0089.5001,1360.00%
2024/06/1100.00092.5091.0001,1820.00%
2024/05/30089.2000.0088.6001,4750.00%
2024/05/29190.40190.1189.1001,5110.00%
中裕首度與美國客戶簽訂CDMO合約 營運添動能Anue鉅亨-12天前
〈美對等關稅〉中裕回應暫無影響 愛滋病新藥足以供應美國市場銷售Anue鉅亨-2025/04/09
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-2025/03/26
中裕 相關文章